Nordisk v. Caraco Pharmaceutical Laboratories, Ltd.

Full title: NOVO NORDISK A/S, et al., Plaintiffs, v. CARACO PHARMACEUTICAL…

Court: United States District Court, E.D. Michigan, Southern Division

Date published: Jul 22, 2010

Case No. 05-40188 (E.D. Mich. Jul. 22, 2010)

Opinion

Case No. 05-40188.

July 22, 2010

ORDER

AVERN COHN, District Judge

Novo Nordisk's objections to DX 394 and DX 477A (Doc. 473) are OVERRULED for the reasons stated on the record on July 20, 2010. Particularly, DX 394 is a demonstrative exhibit displaying in graphic form the results of the testing described in DX 201, DX 61 (which is a duplicate of PX 44) and DX 246, publications which were identified in the testimony. Particularly, DX 477A is a graphic display of diabetic drugs identified in the testimony.

SO ORDERED.